blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2104684

EP2104684 - PEPTIDES FOR USE IN THE TREATMENT OF OBESITY [Right-click to bookmark this link]
StatusThe application has been withdrawn
Status updated on  10.09.2010
Database last updated on 11.05.2024
Most recent event   Tooltip10.09.2010Withdrawal of applicationpublished on 13.10.2010  [2010/41]
Applicant(s)For all designated states
Novo Nordisk A/S
Novo Allé
2880 Bagsværd / DK
[2009/40]
Inventor(s)01 / SENSFUSS, Ulrich
Sankelmarksgade 11, 5. tv.
DK-1676 Copenhagen V / DK
02 / LAU, Jesper
Dybedalsvej 27
DK-3520 Farum / DK
 [2009/40]
Application number, filing date08707960.417.01.2008
[2009/40]
WO2008EP50513
Priority number, dateDK2007000007818.01.2007         Original published format: DK 200700078
[2009/40]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2008087187
Date:24.07.2008
Language:EN
[2008/30]
Type: A1 Application with search report 
No.:EP2104684
Date:30.09.2009
Language:EN
The application published by WIPO in one of the EPO official languages on 24.07.2008 takes the place of the publication of the European patent application.
[2009/40]
Search report(s)International search report - published on:EP24.07.2008
ClassificationIPC:C07K14/68, A61K38/34
[2009/40]
CPC:
C07K14/68 (EP,US); A61P1/16 (EP); A61P15/00 (EP);
A61P19/02 (EP); A61P3/04 (EP); A61P3/06 (EP);
A61P3/10 (EP); A61P35/00 (EP); A61P43/00 (EP);
A61P9/10 (EP); A61P9/12 (EP) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2009/40]
TitleGerman:PEPTIDE ZUR VERWENDUNG BEI DER BEHANDLUNG VON ADIPOSITAS[2009/40]
English:PEPTIDES FOR USE IN THE TREATMENT OF OBESITY[2009/40]
French:PEPTIDES DESTINÉS À ÊTRE UTILISÉS DANS LE TRAITEMENT DE L'OBÉSITÉ[2009/40]
Entry into regional phase18.08.2009National basic fee paid 
18.08.2009Designation fee(s) paid 
18.08.2009Examination fee paid 
Examination procedure18.08.2009Examination requested  [2009/40]
24.11.2009Despatch of a communication from the examining division (Time limit: M06)
13.07.2010Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
08.09.2010Application withdrawn by applicant  [2010/41]
Fees paidRenewal fee
01.02.2010Renewal fee patent year 03
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[Y]WO2004099246  (NOVO NORDISK AS [DK], et al) [Y] 1-16,1-16,1-16 * The whole document; see particularly examples 18,20,22,28 * * The whole document; see particularly examples 18,20,22,28 * * The whole document; see particularly examples 18,20,22,28 *;
 [Y]WO2006005667  (NOVO NORDISK AS [DK], et al) [Y] 1-16,1-16,1-16 * page 41, line 2; claims 1-11,13,38,39 * * page 41, line 2; claims 1-11,13,38,39 * * page 41, line 2; claims 1-11,13,38,39 *;
 [Y]WO2006048449  (NOVO NORDISK AS [DK], et al) [Y] 1-16,1-16,1-16 * claim 1 * * claim 1 * * claim 1 *;
 [Y]WO2006048450  (NOVO NORDISK AS [DK], et al) [Y] 1-16,1-16,1-16 * claim 1 * * claim 1 * * claim 1 *;
 [Y]WO2006048452  (NOVO NORDISK AS [DK], et al) [Y] 1-16,1-16,1-16 * claim 1 * * claim 1 * * claim 1 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.